Perspectives: End Point

EU Studies Costs of Chemical Exposure

Reports say endocrine-disrupting chemicals likely costs billions in health-care expenses.

By Seán Ottewell, Editor at Large
Mar 9, 2015

New research suggests that exposure to endocrine-disrupting chemicals (EDCs) likely costs the European Union (EU) €157 billion ($172 billion) every year in actual health-care expenses and lost earning potential. The findings were outlined in four studies in the March issue of the Journal of Clinical Endocrinology and Metabolism, published by the Endocrine Society, Washington, D.C.

Read More